Let’s look at the key reasons that are pushing CorMedix Inc (CRMD) to new highs

On Friday, CorMedix Inc (NASDAQ: CRMD) opened higher 4.01% from the last session, before settling in for the closing price of $9.73. Price fluctuations for CRMD have ranged from $2.57 to $10.15 over the past 52 weeks.

Healthcare Sector giant saw their annual sales slid by -47.11% over the last five years. Company’s average yearly earnings per share was noted 31.43% at the time writing. With a float of $56.86 million, this company’s outstanding shares have now reached $57.76 million.

The firm has a total of 82 workers. Let’s measure their productivity. In terms of profitability, gross margin is -29.14%, operating margin of -5236.86%, and the pretax margin is -4909.87%.

CorMedix Inc (CRMD) Breakdown of a Key Holders of the stock

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of CorMedix Inc is 1.56%, while institutional ownership is 29.59%. The most recent insider transaction that took place on Mar 13 ’24, was worth 50,718. In this transaction Chief Executive Officer of this company bought 13,561 shares at a rate of $3.74, taking the stock ownership to the 352,839 shares. Before that another transaction happened on Dec 14 ’23, when Company’s Director bought 3,000 for $3.45, making the entire transaction worth $10,350. This insider now owns 12,250 shares in total.

CorMedix Inc (CRMD) Recent Fiscal highlights

If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -0.17 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.21) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 31.43% per share during the next fiscal year.

CorMedix Inc (NASDAQ: CRMD) Trading Performance Indicators

Check out the current performance indicators for CorMedix Inc (CRMD). In the past quarter, the stock posted a quick ratio of 4.43. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 721.64.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.93, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach 0.04 in one year’s time.

Technical Analysis of CorMedix Inc (CRMD)

Analysing the last 5-days average volume posted by the [CorMedix Inc, CRMD], we can find that recorded value of 1.33 million was better than the volume posted last year of 0.63 million. As of the previous 9 days, the stock’s Stochastic %D was 92.78%. Additionally, its Average True Range was 0.48.

During the past 100 days, CorMedix Inc’s (CRMD) raw stochastic average was set at 99.24%, which indicates a significant increase from 98.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.93% in the past 14 days, which was lower than the 69.70% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $6.47, while its 200-day Moving Average is $4.86. Now, the first resistance to watch is $10.32. This is followed by the second major resistance level at $10.53. The third major resistance level sits at $10.88. If the price goes on to break the first support level at $9.76, it is likely to go to the next support level at $9.41. Now, if the price goes above the second support level, the third support stands at $9.20.

CorMedix Inc (NASDAQ: CRMD) Key Stats

There are currently 54,959K shares outstanding in the company with a market cap of 584.53 million. Presently, the company’s annual sales total 0 K according to its annual income of -46,340 K. Last quarter, the company’s sales amounted to 810 K and its income totaled -14,150 K.